Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11453923.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Langerhans cell histiocytosis (LCH) can be a difficult therapeutic problem. We present a 40-year-old woman with a 4-year history of LCH who was successfully treated with low-dose methotrexate (20 mg weekly).
Medical subject headings
- Dermatologic Agents
- Histiocytosis, Langerhans-Cell
- Methotrexate
- Skin Diseases